It is with great excitement that we unveil our network-wide redesign. Please read further to learn more about a few of our new features, and browse around to explore the new site!
Patients with heart failure and reduced ejection fraction (HF-REF) treated with an investigational angiotensin receptor neprilysin Inhibitor (ARNI) are more likely to reduce cardiovascular death and heart failure hospitalization than...
Teens who received the collaborative care intervention in primary care had significantly greater improvements in depressive symptoms than teens who were receiving treatment as usual.

LATEST
Public-private partnerships in ...

The spread of the Ebola virus (EVD) continues to capture world headlines. It has also become of great concern in the ...

Positive results found for ...
Enterovirus D68: 5 ways formulary ...
FDA’s new hep C approval: A step ...
FDA fast tracks ALS drug

FDA APPROVALS
FDA approves bortezomib for ...

FDA approved bortezomib (Velcade, Millennium: The Takeda Oncology Company) for injection for use in previously untreated ...

FDA approves antiemetic agent for ...
FDA’s new hep C approval: A step ...
FDA approves first drug-coated ...

CLINICAL
Study: Pneumococcal vaccine can ...

The 13-valent pneumococcal conjugate vaccine (PCV13) not only prevents pneumococcal illness and death, but also ...

Public-private partnerships in ...
Positive results found for ...
FDA approves antiemetic agent for ...

DRUGS IN PERSPECTIVE
Drug Overview: Zykadia (ceritinib)

Zykadia (ceritinib) is a tyrosine kinase inhibitor that was approved by FDA on April 29, 2014, as a medication for the ...

Drugs in Perspective: Dalvance
Drug Overview: Tasimelteon (Hetlioz)
Drug Overview: Aptiom ...

Latest Tweets Follow